BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7377152)

  • 1. Salicylate therapy in juvenile rheumatoid arthritis. Dose, serum level, and toxicity.
    Doughty RA; Giesecke L; Athreya B
    Am J Dis Child; 1980 May; 134(5):461-3. PubMed ID: 7377152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-induced hepatotoxicity and its effect on juvenile rheumatoid arthritis.
    Bernstein BH; Singsen BH; King KK; Hanson V
    Am J Dis Child; 1977 Jun; 131(6):659-63. PubMed ID: 868818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-induced hepatotoxicity in juvenile rheumatoid arthritis. A prospective study.
    Athreya BH; Moser G; Cecil HS; Myers AR
    Arthritis Rheum; 1975; 18(4):347-52. PubMed ID: 1156454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in the treatment of juvenile arthritis.
    Baum J
    Am J Med; 1983 Jun; 74(6A):10-5. PubMed ID: 6344620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between transaminase concentrations and serum salicylate concentration in juvenile rheumatoid arthritis.
    Miller JJ; Weissman DB
    Arthritis Rheum; 1976; 19(1):115-8. PubMed ID: 1252262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report.
    Mäkelä AL; Tryänä T; Haapasaari J
    Scand J Rheumatol; 1975; 4(4):250-2. PubMed ID: 1198081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic salicylate administration in juvenile rheumatoid arthritis: aspirin "hepatitis" and its clinical significance.
    Schaller JG
    Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):916-25. PubMed ID: 724343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage of salicylates for children with juvenile rheumatoid arthritis. A prospective clinical trial with three different preparations of acetylsalicylic acid.
    Mäkela AL; Yrjänä T; Mattila M
    Acta Paediatr Scand; 1979 May; 68(3):423-30. PubMed ID: 375668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micromeasurement of plasma salicylate in arthritic children.
    Jacobs JC; Pesce M
    Arthritis Rheum; 1978; 21(1):129-32. PubMed ID: 623682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylsalicylic acid and juvenile rheumatoid Arthritis. Effect of dosage interval on the serum salicylic acid level.
    Kvien TK; Olsson B; Høyeraal HM
    Acta Paediatr Scand; 1985 Sep; 74(5):755-9. PubMed ID: 3901663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children with juvenile rheumatoid arthritis treated with salicylates for 15 days, with daily serum salicylate determinations.
    Calabro JJ; Brunstein SL; Staley HL
    Scand J Rheumatol; 1976; 5(4):251-2. PubMed ID: 1006215
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetic monitoring of salicylate therapy in children with juvenile rheumatoid arthritis.
    Pachman LM; Olufs R; Procknal JA; Levy G
    Arthritis Rheum; 1979 Aug; 22(8):826-31. PubMed ID: 465097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benorylate in management of Still's disease.
    Powell RH; Ansell BM
    Br Med J; 1974 Jan; 1(5899):145-7. PubMed ID: 4812408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of monitoring plasma salicylate levels in treating juvenile rheumatoid arthritis. Observations in 42 cases.
    Bardare M; Cislaghi GU; Mandelli M; Sereni F
    Arch Dis Child; 1978 May; 53(5):381-5. PubMed ID: 666351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between saliva salicylate concentration and free or total salicylate concentration in serum of children with juvenile rheumatoid arthritis.
    Levy G; Procknal JA; Olufs R; Pachman LM
    Clin Pharmacol Ther; 1980 May; 27(5):619-27. PubMed ID: 7371360
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroids-salicylate interaction in a case of juvenile rheumatoid arthritis.
    Koren G; Roifman C; Gelfand E; Lavi S; Suria D; Stein L
    Ther Drug Monit; 1987 Jun; 9(2):177-9. PubMed ID: 3617157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of brand on the serum level of aspirin.
    Jochsberger T; Kirschenbaum H; Gaynor H; D'Agostino J
    Drug Intell Clin Pharm; 1983; 17(7-8):550-1. PubMed ID: 6688218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis.
    Rich RR; Johnson JS
    Arthritis Rheum; 1973; 16(1):1-9. PubMed ID: 4692157
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum transaminases during salicylate therapy.
    Russell AS; Sturge RA; Smith MA
    Br Med J; 1971 May; 2(5759):428-9. PubMed ID: 5576002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Salicylate dosage for children with juvenile chronic arthritis].
    Mäkelä AL; Yrjänä T
    Duodecim; 1978; 94(12):771-9. PubMed ID: 357138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.